Top Markets
Coin of the day
Welgene Biotech Co.,Ltd. Welgene Biotech Co.,Ltd.

Welgene Biotech Co.,Ltd.

6661
Rang in Aktien #31671
Welgene Biotech Co.,Ltd. primarily focuses on delivering genetic analysis... Welgene Biotech Co.,Ltd. primarily focuses on delivering genetic analysis services. The company provides comprehensive support for scientific research, employing a range of advanced laboratory techniques such as genetic sequencing, microarray analysis, qPCR verification, nucleic acid extraction and quality control, LCM single cell experimentation, and intricate bioinformatics analysis. A key offering in their portfolio is Cytoscan, an array-based comparative genomic hybridization (CGH) solution. Beyond services, Welgene Biotech also supplies essential laboratory products, including various reagents, consumable items, and specialized instruments, alongside dedicated software solutions. Established in 2003, the company operates from its headquarters in Taipei City, Taiwan.
Aktienkurs
$0.53422367
Marktkapitalisierung
$12.45M
Veränderung (1 Tag)
0.30%
Veränderung (1 Jahr)
-19.98%
Land
TW
Handel Welgene Biotech Co.,Ltd. (6661)

Kategorie

Kursverlauf für Welgene Biotech Co.,Ltd. (6661)
Höchster Schlusskurs: $0.54 am 2026-08-01

Niedrigster Schlusskurs: $0.82 am 2017-10-01
Kursverlauf der Aktie von Welgene Biotech Co.,Ltd. von 2017 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 0.69%
2025 -18.28%
2024 -0.14%
2023 1.28%
2022 -17.81%
2021 -30.60%
2020 48.22%
2019 32.38%
2018 -8.61%
2017 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$586.41 20.28%
US
$202.37 -3.18%
US
$24.23 79.49%
CN
$314.26 95.01%
US
$544.68 -14.61%
US